ReviewDialogues in health2026

Early mineralocorticoid receptor antagonism for end-organ protection in hypertension: Implications for disparities and rethinking the timing paradigm.

Camellus O EzeugwuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.